InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by Holmlin R. Erik, Chairman & CEO. Insider active across 3 companies, notably Bionano Genomics, Inc. In total, 5 filings have been logged. Total volume traded: €16k. The latest transaction was filed on 12 May 2022 — Retenue fiscale. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations5 total
€68,11350,141 shares@ €1.35840.41% mcap81.4% of flow
Common Stock
SEC:0001209191-22-029457:0·
€7,7632,200 shares@ €3.5287100.0% of flow
Common Stock
SEC:0001209191-21-067229·
Ideal exit: 26 Aug 2022 (T+270)
€7,7632,200 shares@ €3.52870.047% mcap9.3% of flow
Common Stock
SEC:0001209191-21-067229:0·
Ideal exit: 26 Aug 2022 (T+270)
0290,000 shares0
Common Stock
SEC:0001209191-21-032934·
0290,000 shares0
Common Stock
SEC:0001209191-21-032934:0·
5 of 5 declarations
About Holmlin R. Erik
R. Erik Holmlin is President and CEO of Bionano Genomics, Inc. He is responsible for the strategic and operational leadership of the company, overseeing all activities to ensure growth and innovation. With extensive experience in the biotechnology sector, he plays a key role in shaping the company's vision and objectives. His leadership is essential for navigating a competitive environment.
